|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.32 USD | +1.28% |
|
+1.08% | +8.87% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -8.62x | 4.02x | 3.79x | -7x | -6.57x | 2.14B | ||
| 0.6% | 0.68% | 16.82x | 1.94x | 3.66x | 9.83x | 10.82x | 66.11B | ||
| 0.58% | 0.59% | 27.43x | 4.12x | 5.64x | 16.57x | 20.94x | 55.3B | ||
| -.--% | -.--% | 34.85x | 6.99x | 11.81x | 22.36x | 26.28x | 42.44B | ||
| 3.31% | 3.39% | -46.4x | 2.53x | 3.26x | 9.63x | 11.23x | 41.28B | ||
| -.--% | -.--% | -9.48x | 5.55x | 13.79x | -8.46x | -8x | 32.46B | ||
| -.--% | -.--% | 31.76x | 1.63x | 3.6x | 11.15x | 12.97x | 30.78B | ||
| -.--% | -.--% | 16.78x | 3.36x | 3.2x | 9.7x | 9.61x | 23.1B | ||
| -.--% | 0.06% | 56.99x | 5.76x | 6.38x | 44.22x | 40.9x | 20.06B | ||
| -.--% | -.--% | 26.81x | 3.75x | 5.49x | 14.75x | 20.37x | 17.19B | ||
| -.--% | -.--% | -35.74x | -6.2x | 16.56x | -50.36x | -52.34x | 15.23B | ||
| -.--% | -.--% | -123.08x | 12849.58x | 12.56x | -111.25x | -122.24x | 12.48B | ||
| 0.15% | 0.16% | 60.56x | 24.69x | 36.76x | 51.99x | 53.62x | 11.57B | ||
| -.--% | -.--% | 16.69x | - | 3.56x | 13.05x | 15.64x | 11.36B | ||
| -.--% | -.--% | 48.6x | - | - | - | - | 11.05B | ||
| 2.82% | 3.26% | 11.92x | 1.04x | 1.81x | 7.3x | 9.78x | 6.24B | ||
| 1.46% | 1.62% | 15.48x | 1.42x | 2.83x | 7.33x | 8.88x | 6.2B | ||
| 0.36% | 0.42% | 28.88x | - | 7.77x | 20.62x | 24.62x | 5.88B | ||
| Average | 0.51% | 0.57% | 9.46x | 860.68x | 8.38x | 3.61x | 4.50x | 22.83B | |
| Weighted average by Cap. | 0.58% | 0.62% | 11.01x | 423.11x | 7.51x | 7.85x | 9.27x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















